From peptides to stem cells, a physician shows h
Author: Michael
Preclinical results spotlight a new AI-driven ap
New research maps the slow cascade from brief ta
Company initially targets ‘exosome-based welln
Drug could offer weekly at-home injections, simp
Mesoblast Limited, a global developer of allogene
ProMIS Neurosciences Inc.
NeuroEM Therapeutics, a clinical-stage biotechnol
Illumina, Inc.
GenSight Biologics S.A.